Jill A. Bell

2.3k total citations
63 papers, 1.4k citations indexed

About

Jill A. Bell is a scholar working on Hematology, Oncology and Physiology. According to data from OpenAlex, Jill A. Bell has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 15 papers in Oncology and 12 papers in Physiology. Recurrent topics in Jill A. Bell's work include Acute Myeloid Leukemia Research (13 papers), Muscle metabolism and nutrition (7 papers) and Musculoskeletal pain and rehabilitation (7 papers). Jill A. Bell is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Muscle metabolism and nutrition (7 papers) and Musculoskeletal pain and rehabilitation (7 papers). Jill A. Bell collaborates with scholars based in United States, United Kingdom and Japan. Jill A. Bell's co-authors include Leslie A. Consitt, Christopher Sexton, Joseph A. Houmard, Elena Volpi, Blake B. Rasmussen, Satoshi Fujita, Jerson G. Cadenas, Heather L. Gelhorn, Peter Classi and Karin S. Coyne and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jill A. Bell

59 papers receiving 1.4k citations

Peers

Jill A. Bell
Giorgio Valenti Italy
James Gibney Ireland
Magdalena Taube Sweden
Carlo Cisari Italy
Maple M. Fung United States
Eckhard Schönaü Germany
Michael Bliziotes United States
Richard T. Lee United States
Tomoki Aoyama Japan
David Bates United Kingdom
Giorgio Valenti Italy
Jill A. Bell
Citations per year, relative to Jill A. Bell Jill A. Bell (= 1×) peers Giorgio Valenti

Countries citing papers authored by Jill A. Bell

Since Specialization
Citations

This map shows the geographic impact of Jill A. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill A. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill A. Bell more than expected).

Fields of papers citing papers by Jill A. Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill A. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill A. Bell. The network helps show where Jill A. Bell may publish in the future.

Co-authorship network of co-authors of Jill A. Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Jill A. Bell. A scholar is included among the top collaborators of Jill A. Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill A. Bell. Jill A. Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arizmendi, Cara, et al.. (2024). The FACT-GP5 as a global tolerability measure: responsiveness and robustness to missing assessments. Quality of Life Research. 33(10). 2869–2880. 1 indexed citations
2.
Duarte, Rui, Rachel Houten, Sarah J Nevitt, et al.. (2022). Screening trials of spinal cord stimulation for neuropathic pain in England—A budget impact analysis. SHILAP Revista de lepidopterología. 3. 974904–974904. 6 indexed citations
3.
Nathwani, Nitya, et al.. (2022). Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma. Supportive Care in Cancer. 30(7). 5859–5869. 9 indexed citations
4.
Regnault, Antoine, Farrah Pompilus, Rafael Bejar, et al.. (2021). Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30. Journal of Patient-Reported Outcomes. 5(1). 60–60. 8 indexed citations
5.
Chadwick, Raymond, Sam Eldabe, Ganesan Baranidharan, et al.. (2020). To Trial or Not to Trial Before Spinal Cord Stimulation for Chronic Neuropathic Pain: The Patients’ View From the TRIAL-STIM Randomized Controlled Trial. Neuromodulation Technology at the Neural Interface. 24(3). 459–470. 21 indexed citations
6.
Bell, Jill A., Aaron Galaznik, Farrah Pompilus, et al.. (2019). A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. Journal of Patient-Reported Outcomes. 3(1). 35–35. 10 indexed citations
7.
Morrison, Vicki A., Yaping Shou, Jill A. Bell, et al.. (2019). Treatment Patterns and Survival Outcomes in Patients With Follicular Lymphoma: A 2007 to 2015 Humedica Database Study. Clinical Lymphoma Myeloma & Leukemia. 19(4). e172–e183. 16 indexed citations
8.
Bell, Jill A., et al.. (2018). P3.15-03 Capturing the Patient Experience for the Treatment of EGFR Exon 20 Mutations in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(10). S991–S992. 1 indexed citations
9.
10.
11.
12.
Galaznik, Aaron, Jill A. Bell, Michael E. Stokes, et al.. (2016). Systematic Review of Therapy Used in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Blood. 128(22). 3562–3562. 1 indexed citations
13.
Bell, Jill A., Marco DiBonaventura, Edward A. Witt, Rami Ben‐Joseph, & Bryce B. Reeve. (2016). Use of the SF-36v2 Health Survey as a Screen for Risk of Major Depressive Disorder in a US Population-based Sample and Subgroup With Chronic Pain. Medical Care. 55(2). 111–116. 8 indexed citations
14.
Ben‐Joseph, Rami, et al.. (2016). Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone. Journal of Managed Care & Specialty Pharmacy. 22(4). 358–366. 1 indexed citations
15.
16.
Corey‐Lisle, Patricia K., Ronald Peck, Pralay Mukhopadhyay, et al.. (2011). Q‐TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer. Cancer. 118(2). 461–468. 19 indexed citations
17.
Drummond, Micah J., Jill A. Bell, Satoshi Fujita, et al.. (2008). Amino acids are necessary for the insulin-induced activation of mTOR/S6K1 signaling and protein synthesis in healthy and insulin resistant human skeletal muscle. Clinical Nutrition. 27(3). 447–456. 57 indexed citations
18.
Consitt, Leslie A., Jill A. Bell, & Joseph A. Houmard. (2008). Intramuscular lipid metabolism, insulin action, and obesity. IUBMB Life. 61(1). 47–55. 130 indexed citations
19.
Bell, Jill A., Elena Volpi, Satoshi Fujita, et al.. (2006). Skeletal Muscle Protein Anabolic Response to Increased Energy and Insulin Is Preserved in Poorly Controlled Type 2 Diabetes. Journal of Nutrition. 136(5). 1249–1255. 38 indexed citations
20.
Robertson, Robert J., Fredric L. Goss, Jill A. Bell, et al.. (2002). Self-regulated cycling using the children???s OMNI Scale of Perceived Exertion. Medicine & Science in Sports & Exercise. 34(7). 1168–1175. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgio Valenti Breakdown of academic impact, for papers by James Gibney Breakdown of academic impact, for papers by Magdalena Taube Breakdown of academic impact, for papers by Carlo Cisari Breakdown of academic impact, for papers by Maple M. Fung Breakdown of academic impact, for papers by Eckhard Schönaü Breakdown of academic impact, for papers by Michael Bliziotes Breakdown of academic impact, for papers by Richard T. Lee Breakdown of academic impact, for papers by Tomoki Aoyama Breakdown of academic impact, for papers by David Bates
Rankless by CCL
2026